Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes
Authors:
- Junnosuke MiuraJMJunnosuke Miura
- Sho-Ichi YamagishiSYSho-Ichi Yamagishi
- Yasuko UchigataYUYasuko Uchigata
- Masayoshi TakeuchiMTMasayoshi Takeuchi
- Hiroshi YamamotoHYHiroshi Yamamoto
- Zenji MakitaZMZenji Makita
- Yasuhiko IwamotoYIYasuhiko Iwamoto
- 1 January 2003
- journal article
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 17 (1) , 16-21
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene ExpressionJournal of Biological Chemistry, 1999
- Upregulation of Retinal Vascular Endothelial Growth Factor mRNAs in Spontaneously Diabetic Rats without Ophthalmoscopic RetinopathyOphthalmic Research, 1998
- The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinasDiabetologia, 1997
- Advanced Glycation End Products-driven Angiogenesis in VitroJournal of Biological Chemistry, 1997
- The Advanced Glycation End Product, N∊-(Carboxymethyl)lysine, Is a Product of both Lipid Peroxidation and Glycoxidation ReactionsJournal of Biological Chemistry, 1996
- Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats.Journal of Clinical Investigation, 1996
- Receptor-Mediated Toxicity to Pericytes of Advanced Glycosylation End Products: A Possible Mechanism of Pericyte Loss in Diabetic MicroangiopathyBiochemical and Biophysical Research Communications, 1995
- Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failureThe Lancet, 1994
- Advanced Glycosylation End Products in Patients with Diabetic NephropathyNew England Journal of Medicine, 1991
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988